Glimpsing The Future At Gargantuan Health Tech Showcase
Innovations to help consumers manage their health were on display at the nation鈥檚 largest health technology conference that attracted more than 40,000 health industry professionals to Orlando.
Health Industry
2,101-2,120 of 4,019 results
-
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 ‘Medicare-For-All’ For Dummies
The 鈥淢edicare鈥揻or-all鈥 debate is already in full swing, but what does that phrase even mean? Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner for a beginner鈥檚 guide to the next big health policy debate. For 鈥渆xtra credit,鈥 the panelists provide their favorite health policy stories of the week, and as a special Valentine鈥檚 Day bonus, their favorite #HealthPolicyValentines.
-
Beyond Beltway’s ‘Medicare-For-All’ Talk, Democrats In States Push New Health Laws
As calls for "Medicare-for-all" grow louder among Democrats in Congress, Democratic governors and mayors have been pushing ahead with urgency to corral medical costs and bring health care to those who remain uninsured.
By Sarah Varney -
Can California Beat The Federal Government In Lowering Drug Prices?
Unwilling to wait for federal action, California Gov. Gavin Newsom says he has a plan that could extract discounts from drugmakers and save the state money 鈥 one he hopes other states can join.
-
A 鈥楩ountain Of Youth鈥 Pill? Sure, If You鈥檙e A Mouse.
The race for the cure to aging sparks hope and hype among top scientists 鈥 plus billions of dollars in investment.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 A 鈥楬ealthy鈥 State Of The Union
Health was a featured player in President Donald Trump鈥檚 2019 State of the Union address. The president set goals to bring down prescription drug prices, end the HIV epidemic in the U.S. and cure childhood cancer, among other things. Margot Sanger-Katz of The New York Times, Anna Edney of Bloomberg News and Alice Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss these issues and, for 鈥渆xtra credit,鈥 provide their favorite health policy stories of the week. Rovner also interviews KHN senior correspondent Phil Galewitz about the current 鈥淏ill of the Month鈥 feature.
-
Trump Administration Salutes Parade Of Generic Drug Approvals, But Hundreds Aren鈥檛 For Sale
President Donald Trump and FDA officials have pointed to a surge in generic drug approvals, but a data analysis indicates almost half haven鈥檛 reached the market.
By Sydney Lupkin and Jay Hancock -
Trump Highlights Health Agenda With Vow To Lower 鈥楿nfair鈥 Drug Prices
The president laid out a series of goals, including lowering prescription prices, pursuing an end to the HIV epidemic and boosting funding for childhood cancers.
By Julie Rovner -
Ideas To Curb Surprise Medical Bills Percolate With Rare Bipartisan Push
The recent declaration by President Donald Trump that taming unexpected medical bills would be a top priority for his administration echoed through the halls of Congress.
By Shefali Luthra and Emmarie Huetteman -
Transparent Hospital Pricing Exposes Wild Fluctuation, Even Within Miles
A new federal rule requires hospitals to post their prices online. These lists reveal the wildly different charges for basic procedures and services, but consumers will have a hard time putting this information to use.
-
Task Force Outlines Strategy To Address California鈥檚 Shortfall Of Health Workers
A new report by a coalition of health, education and labor leaders concludes that the state must build a larger and more culturally diverse pool of medical, mental health and home care professionals to meet the needs of a growing population. The findings point to a big challenge for Gov. Gavin Newsom as he seeks to extend health insurance to many of California鈥檚 nearly 3 million uninsured residents.
By Anna Gorman -
Winners And Losers Under Bold Trump Plan To Slash Drug Rebate Deals
The White House and HHS want to eliminate a 鈥渟hadowy system of kickbacks鈥 in the drug industry pipeline.
By Jay Hancock -
Lawsuit Details How The Sackler Family Allegedly Built An OxyContin Fortune
WBUR and other media organizations sued Purdue Pharma to force the release of previously redacted information in a case brought by the Massachusetts attorney general.
-
Patients Suffer When Health Care Behemoths Quarrel Over Contracts
The latest example is Sutter Health and Anthem Blue Cross, whose failure to seal a deal is causing Anthem members to worry they may not have access to one of the dominant hospital chains in Northern California. Across the U.S., the stakes in such contract fights have risen, as health systems and insurers battle to increase their market share.
-
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
-
Nonprofit Dental Insurer Under Scrutiny For 鈥楩lagrant鈥 Spending
Delta Dental of California, with more than 36 million enrollees across the country, is looking to buy a stake in a for-profit insurance company based in Oregon. Consumer advocates are calling on regulators to scrutinize the transaction, arguing that it is just the latest questionable move by the nonprofit dental insurer whose corporate practices may be out of step with its tax-exempt status.
-
Podcast: KHN鈥檚 鈥榃hat The Health?鈥 Live From D.C.: A Look Ahead At Health Policy In 2019
Congress and President Donald Trump are starting to wrestle with health policy issues, and health is already a key debate point in the early run-up to the 2020 Democratic presidential primaries. Might any major health policy legislation be passed and signed this year? Joanne Kenen of Politico, Anna Edney of Bloomberg News and Kimberly Leonard of The Washington Examiner, along with special guest Tom Miller of the American Enterprise Institute, join KHN鈥檚 Julie Rovner to discuss these issues and take questions from a live studio audience.
-
Ads For Short-Term Plans Lacking ACA Protections Swamped Consumers鈥 Online Searches
People looking for insurance during the recent open enrollment period were frequently directed to websites promoting plans that are not required to offer the federal health law鈥檚 consumer guarantees.
-
Congress Wades Into Emotional Debate Over High-Cost Prescription Drugs
Key House and Senate committees kick off hearings on drug prices, and patients鈥 families weigh in with tragic stories.
By Emmarie Huetteman and Rachel Bluth